Steve Silberman told how an increasing number of medications are unable to beat dummy pills called placebos in head-to-head clinical testing, a point that has huge implications for the pharmaceutical industry. Only belatedly, he found, have researchers been trying to fully understand the power of the body’s response to placebos, and the real potential of that response to affect human health. Guy Gugliotta, a freelance science writer, said Silberman’s piece was “superbly written and superbly researched.” Mary Knudson, a freelance writer and journalism teacher at The Johns Hopkins University, called Silberman’s piece “a fascinating account,” told through an examination of medical history, drug trial records, and extensive interviews with scientists. “I learned that the humble phrase ‘the placebo effect,’ often used glibly to dismiss the benefits of quack therapies, describes a complex web of relationships—between doctor and patient, mind and body, and hope and affliction—that has a very concrete impact on our state of being,” Silberman said. “The pure joy of science reporting is having the perspective of a story open out like that. You start out by looking hard at some small phenomenon, and end up getting a glimpse of the higher orders at work in our everyday lives.”